News & Events

Events

Dr. Steven Petrou Presents Data on Antisense Oligonucleotide Development Program for SCN2A Epilepsy at 2019 World Orphan Drug Congress

April 10th, 2019 Gaylord National Harbor Hotel, Oxon Hill, Maryland

AES Late-Breaking Abstract Presentation: Antisense oligonucleotide therapy for SCN2A gain-of-function epilepsies

In The News